Author: WTN News

Can an employer read a worker's email? Businesses certainly have the technical capability to look at the emails sent from their computers, whether it's transmitted through a company or a private email account. The question really is whether an employee can have any expectation of privacy? It...

MADISON - DNASTAR, a leading bioinformatics software company, and Wageningen University and Research centre in Wageningen, the Netherlands announced today the signing of a broad site license agreement for the use of Lasergene® sequence analysis software developed by DNASTAR. Under the terms of the site license,...

Now that we’ve all actually seen Chrome OS, the immediate reaction that most are jumping to is that it won’t be killing Windows anytime soon. Obviously. But that doesn’t mean it won’t hurt Microsoft, and apply long-term pressure to the dominant OS. In fact, Google’s...

The NY Times reported today on how the concept of shared; low cost supercomputers are being paired with high performance computers from companies with strong Wisconsin Roots including as Cray and Silicon Graphics. The story revealed how users and developers of supercomputer users are using...

The first half of 2009 showed the tough road biotech, and other industries, had to hoe in order to survive. Earlier forecast this year were that many biotech companies would fail, go under, be delisted from the different exchanges, or barely hang on. But like...

Former Wisconsin Gov. Tommy Thompson is crisscrossing the country giving speeches, appearing on cable news shows and writing opinion pieces - all in an attempt to influence the national debate on health care reform. His message: that the health care system needs a major overhaul, that...

Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. The study included 35 patients who received CD 133+...